Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04769310 · ClinicalTrials.gov registry record · NA

Advanced Cardiac Imaging To Predict Embolic Stroke On Brain MRI: A Pilot Study

A NA study of Stroke and Atrial Fibrillation, sponsored by Tulane University.

Completed
Registry status
NA
Development phase
5
Enrollment target
1
Study location

NCT04769310: Completed NA study of Stroke and Atrial Fibrillation, sponsored by Tulane University.

NCT04769310 is a NA study of Stroke and Atrial Fibrillation that has completed, run by Tulane University. The registered enrollment target is 5 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04769310, a NA study of Stroke and Atrial Fibrillation, has completed, sponsored by Tulane University.

COMPLETED
Registry status
NA
Development phase
5 participants
Enrollment target
1
Study location

Study Summary

Demonstrating the pathophysiological link between Left Atrial (LA) and Left Atrial Appendage (LAA) pathology and embolic strokes in non-Atrial Fibrillation (AF) individuals represents a major advance in stroke prevention strategies. Instead of relying on non-specific criteria for stroke risk assessment, the investigators propose to identify individuals with high-risk of embolic stroke using imaging criteria that reflect the underlying pathophysiology of embolic stroke of cardiac origin. the investigators can therefore lay the groundwork for future anticoagulation strategies for stroke prevention beyond AF.

Primary Outcome

The covert embolic cerebral infarcts are defined as the presence of asymptomatic non-lacunar embolic infarct (acute or chronic based on MRI appearance), in the cortex, and juxtacortical regions, and cerebellum. They will be identified using brain MRI.

Conditions Studied

Stroke Atrial Fibrillation Stroke, Ischemic Stroke, Cardiovascular Vascular Cognitive Impairment Strokes Thrombotic

Interventions

  • DEVICE Cardiac and Brain MRI

Study Locations (1)

Louisiana

  • Tulane University Medical Center - New Orleans

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2021-04-26
Est. Completion 2026-01-27
Phase NA
Tulane University

73 total trials

What the finished NCT04769310 record still lists

NCT04769310 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).

The record links to 6 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Cardiac and Brain MRI is the first listed.

NCT04769310 reports a single indexed study location in Louisiana.

Frequently Asked Questions

What is clinical trial NCT04769310 about?

NCT04769310 is a clinical study titled "Advanced Cardiac Imaging To Predict Embolic Stroke On Brain MRI: A Pilot Study". Demonstrating the pathophysiological link between Left Atrial (LA) and Left Atrial Appendage (LAA) pathology and embolic strokes in non-Atrial Fibrillation (AF) individuals represents a major advance in stroke prevention strategies. Instead of relying on non-specific criteria for stroke risk assessm...

What is the current status of trial NCT04769310?

This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2021-04-26. Estimated completion is 2026-01-27.

What conditions does trial NCT04769310 study?

This clinical trial studies the following conditions: Stroke, Atrial Fibrillation, Stroke, Ischemic, Stroke, Cardiovascular, Vascular Cognitive Impairment.

What interventions are being tested in trial NCT04769310?

The interventions under investigation include: Cardiac and Brain MRI (DEVICE).

Who is sponsoring clinical trial NCT04769310?

This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04769310 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04769310's enrollment target sits among peer trials

5 439th of 454 higher than 11 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT04769310, the US trial registry maintained by the National Library of Medicine. NCT04769310 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.